GSK Lifts Long-Term Outlook on Drug Pipeline, Buys Back Shares GSK Lifts Long-Term Outlook on Drug Pipeline, Buys Back Shares

cafead

Administrator
Staff member
  • cafead   Feb 05, 2025 at 11:32: AM
via GSK Plc plans to buy back £2 billion ($2.5 billion) of shares as it raised its long-term growth outlook on optimism around the drug pipeline.

article source